Kappac Pharma Ltd. - Research Center
506938 KAPPH Group (XC) BSE data
Results
|
Quarterly
|
Statement
|
|
More
|
|
Quarterly results in brief
(Rs crore)
|
Mar' 21 |
Dec' 20 |
Sep' 20 |
Jun' 20 |
Mar' 20 |
Sales |
- |
- |
- |
- |
- |
Operating profit |
- |
-0.01 |
- |
- |
- |
Interest |
- |
- |
- |
- |
- |
Gross profit |
-1.99 |
-0.20 |
- |
- |
- |
EPS (Rs) |
-0.66 |
-0.07 |
- |
- |
- |
Quarterly
results in details
|
Mar' 21 |
Dec' 20 |
Sep' 20 |
Jun' 20 |
Mar' 20 |
Other income |
-1.99 |
-0.19 |
- |
- |
- |
Stock adjustment |
- |
- |
- |
- |
- |
Raw material |
- |
- |
- |
- |
- |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
- |
- |
- |
- |
- |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
- |
0.01 |
- |
- |
- |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
- |
- |
- |
- |
- |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
-1.99 |
-0.20 |
- |
- |
- |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
30.27 |
30.27 |
30.27 |
30.27 |
30.27 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
- |
- |
- |
- |
- |
GPM (%) |
- |
- |
- |
- |
- |
NPM (%) |
- |
- |
- |
- |
- |